Padagis US LLC recalls Nystatin Cream USP
- Published
- 22 Jul 2026
- Units affected
- 180,936 tubes
- Agency
- FDA
- Country
- United States
The hazard
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
- Brand / company
- Padagis US LLC
- Codes / lots
- Lot #: 205060, Exp 09/30/2027
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 22 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.